The effectiveness of the Masterson curette in sampling the endometrial cavity.
The Masterson curette was used to sample the endometrial cavity of 25 women prior to scheduled hysterectomy for benign or malignant pathology. Adequate amount of tissue was obtained in 20 (87%) of 23 patients who did not have endometrial atrophy. The Masterson curettage detected all seven cases of endometrial hyperplasia or adenocarcinoma for a sensitivity of 100%. However, the Masterson curette does not sample the entire endometrial cavity. If abnormal uterine bleeding persists despite normal histology on curettings obtained with the Masterson or other endometrial sampling device, hysteroscopy is recommended.
Reddington
L
L
Department of Obstetrics, Gynecology, Medical College of Pennsylvania, Philadelphia 19129, USA.
Hernandez
E
E
Balsara
G
G
Hughes
D
D
Anderson
L
L
Heller
P B
PB
D000230:Adenocarcinoma / Q000473:pathology; D000328:Adult; D000368:Aged; D001284:Atrophy; D003475:Curettage / Q000295:instrumentation*; D003581:Cytodiagnosis / Q000295:instrumentation*; D004714:Endometrial Hyperplasia / Q000473:pathology; D016889:Endometrial Neoplasms / Q000473:pathology*; D004717:Endometrium / Q000473:pathology*; D005260:Female; D006801:Humans; D007044:Hysterectomy; D015907:Hysteroscopy; D007889:Leiomyoma / Q000473:pathology; D008875:Middle Aged; D012680:Sensitivity and Specificity; D014592:Uterine Hemorrhage / Q000473:pathology; D014594:Uterine Neoplasms / Q000473:pathology